title: Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study Group.
authors.forename: N E
authors.initials: NE
authors.lastname: Kay
authors.forename: M M
authors.initials: MM
authors.lastname: Oken
authors.forename: N
authors.initials: N
authors.lastname: Bone
authors.forename: R A
authors.initials: RA
authors.lastname: Kyle
authors.forename: P
authors.initials: P
authors.lastname: Greipp
authors.forename: B
authors.initials: B
authors.lastname: Van Ness
authors.forename: T
authors.initials: T
authors.lastname: Leong
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D000918:Antibody Specificity; D018941:Antigens, CD19 / Q000097:blood* / Q000276:immunology; D016175:B-Lymphocyte Subsets / Q000737:chemistry*; D019070:Cell Lineage; D015331:Cohort Studies; D016650:Fluorescein-5-isothiocyanate; D005456:Fluorescent Dyes; D006801:Humans; D009101:Multiple Myeloma / Q000097:blood*; D009363:Neoplasm Proteins / Q000097:blood* / Q000276:immunology; D010799:Phycoerythrin
chemical_list: D000911:Antibodies, Monoclonal; D018941:Antigens, CD19; D005456:Fluorescent Dyes; D009363:Neoplasm Proteins; D010799:Phycoerythrin; D016650:Fluorescein-5-isothiocyanate